Application of Modern Biotechnological and Bioinformatics Techniques for the Development of Virus-Like Particles for Diagnostic and Therapeutic Applications
Is a biotech start-up that provides R&D services and solutions in bioengineering of biological nanostructures tailored to individual customer needs.
Application of Modern Biotechnological and Bioinformatics Techniques for the Development of Virus-Like Particles for Diagnostic and Therapeutic Applications
Our specialists have extensive expertise in designing and manufacturing both enveloped and non-enveloped VLPs.
To fulfill the expectations of the market we offer a service of producing polyclonal antibodies.
NaNoExpo is a biotech start-up that provides R&D services and solutions in bioengineering of biological nanostructures tailored to individual customer needs (e.g., exposure of selected epitopes/peptides on the surface of nanostructures, chimeric virus-like particles (VLPs), as well as biological nanostructures able to carry genetic material).
Our specialists have extensive expertise in designing and manufacturing both enveloped and non-enveloped VLPs. Additionally, we design antigens for vaccine development as well as diagnostic tests using protozoan, insect and mammalian cell-based platforms. Moreover, to fulfill the expectations of the market we offer a service of producing polyclonal antibodies.
Scientific Director
Molecular Biologist, Specialist in recombinant vaccine technology and virus-like particles (VLPs). Graduated Biotechnology at the Intercollegiate Faculty of Biotechnology – UG and MUG (major: molecular virology) and was an employee at the Laboratory for Recombinant Vaccines since 2003 - 2015. Laureate of the 6th edition LIDER program of the National Centre for Research and Development. Since 2016 leader of the Bioengineering of Biological Nanostructures Team and the Project Manager of " NaNoEXpo system - as an innovative technology of the production process of new generation vaccines". Founder and CEO of NanoExpo and Sky Way Biolab Company. In 2020, she established the Department of In vitro Studies at the Institute of Biotechnology and Molecular Medicine.Author and co-author of many scientific papers, as well as 10 patents. International invited speaker in the field of influenza virus research and interdyscyplinary expert in Biotechnology field esspetially in modern molecular diagnostic and next generation therapeutics.
Experience Doctors
Clinical Dicisions
Top Global Providers
